MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients (MOTIVATE-HF)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02894502 |
Recruitment Status :
Completed
First Posted : September 9, 2016
Results First Posted : February 24, 2021
Last Update Posted : March 17, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Heart Failure | Behavioral: Motivational interviewing | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 510 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Supportive Care |
Official Title: | MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients (MOTIVATE-HF): Study Protocol of a Three-arm Multicenter Randomized Controlled Trial |
Study Start Date : | June 2014 |
Actual Primary Completion Date : | October 2018 |
Actual Study Completion Date : | October 2018 |

Arm | Intervention/treatment |
---|---|
Experimental: Motivational interviewing only for patients
In this arm the interventions will be delivered only to patients
|
Behavioral: Motivational interviewing
The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines. |
Experimental: Motivational interviewing to patients and caregivers
In this arm the interventions will be delivered both to patients and caregivers
|
Behavioral: Motivational interviewing
The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines. |
No Intervention: Control group
This Group will receive the usual care
|
- Self-care Maintenance in Patients [ Time Frame: 3 months from the intervention ]Self-care in HF patients will be measured with the Self-Care of HF Index V.6.2. Since this instrument has three separate scales, we considered as a primary outcome the score of the Self-care Maintenance scale. The Self-Care Maintenance scale has a score between 0 and 100 with higher score meaning better self-care. Self-Care Maintenance is considered adequate when the score is at least 70.
- Burden of HF Symptoms in Patients [ Time Frame: 3, 6, 9 and 12 months from the intervention ]Burden of HF symptoms will be measured with the Heart Failure Somatic Perception Scale (HFSPS). The HFSPS has a range score between 0 and 90; the higher the score, the higher the burden of symptoms caused by heart failure.
- Patient and Caregiver Generic Physical and Mental Quality of Life [ Time Frame: 3, 6, 9 and 12 months from the intervention ]Patient and caregiver generic physical and mental quality of life will be assessed with the Short Form 12 (SF-12).
- Patient and Caregiver Anxiety and Depression [ Time Frame: 3, 6, 9 and 12 months from the intervention ]Patient and caregiver anxiety and depression will be evaluated with the Hospital Anxiety and Depression Scale
- Patient HF Specific Quality of Life [ Time Frame: 3, 6, 9 and 12 months from the intervention ]Patient HF specific quality of life will be evaluated with the Kansas City Cardiomyopathy Questionnaire
- Patient and Caregiver Quality of Nocturnal Sleep [ Time Frame: 3, 6, 9 and 12 months from the intervention ]We will use the Pittsburgh Sleep Quality Index
- Patient and Caregiver Mutuality [ Time Frame: 3, 6, 9 and 12 months from the intervention ]We will use the Mutuality Scale
- Caregiver Preparedness [ Time Frame: 3, 6, 9 and 12 months from the intervention ]Caregiver Preparedness will be evaluated with the Caregiver Preparedness Scale
- Caregiver Perceived Social Support [ Time Frame: 3, 6, 9 and 12 months from the intervention ]We will use the Multidimensional Scale of Perceived Social Support Scale
- Patient Hospitalizations [ Time Frame: 3, 6, 9 and 12 months from the intervention ]The number of patient hospitalizations will be measured asking the caregiver how many time the patient was hospitalized from at 3, 6, 9 and 12 months from the intervention.
- Use of Emergency Services [ Time Frame: 3, 6, 9 and 12 months from the intervention ]How many times the patient has used the emergency services will be evaluated by asking the caregiver how many time the patient used after 3, 6, 9 and 12 months from the intervention.
- Death [ Time Frame: 3, 6, 9 and 12 months from the intervention ]Death rates will be evaluated in the three arms of the study by caregiver interview at 3, 6, 9 and 12 months from the intervention.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
Diagnosis of HF (for patient), New York Heart Association (NYHA) functional class II- IV (for patient), Inadequate self-care assessed with the Self-Care Heart Failure Index (for patient), Being the informal caregiver of the patients (for caregiver).
Exclusion criteria:
Severe cognitive impairment evaluated with the Six-item screener (for patient), Acute coronary syndrome during the last three months (for patient), Living in a residential settings (e.g., nursing home) (for patient), Patients not willing to participate in the study (for caregiver).

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02894502
Italy | |
University of Rome Tor Vergata | |
Rome, Italy, 00135 |
Documents provided by Ercole Vellone, University of Rome Tor Vergata:
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Ercole Vellone, Assistant Professor, University of Rome Tor Vergata |
ClinicalTrials.gov Identifier: | NCT02894502 |
Other Study ID Numbers: |
121/13 |
First Posted: | September 9, 2016 Key Record Dates |
Results First Posted: | February 24, 2021 |
Last Update Posted: | March 17, 2021 |
Last Verified: | February 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | In case there will be the possibility to share the data, this will be done after data de-identification |
Self-care Motivational interviewing Heart failure Caregivers |
Heart Failure Heart Diseases Cardiovascular Diseases |